Latest News

US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell



MONTPELLIER, France–(BUSINESS WIRE)–Euronext: MEDCL “Clinical development will become a significant part of MedinCell’s expenses and will define the time to market of our products. Bringing on board Richard, with his wealth of knowledge in pharmaceutical development, clinical trial strategy and design optimization will be instrumental to our performance,” states Christophe Douat, CEO of MedinCell. To access the complete version of the press release, visit https://invest.medincell.com/#news Ab

Source link

Related posts

Xenoscope Disposable 5mm Laparoscope FDA Cleared

Newsemia

Study: Low level of exposure to traffic related PM10 can be harmful

Newsemia

Prenatal stress may be involved in shaping psychiatric resilience later in life

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World